The solubility ceiling: a rationale for continuous infusion amphotericin B therapy?
Lewis
Russell E
RE
Wiederhold
Nathan P
NP
D000666:Amphotericin B / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D003840:Deoxycholic Acid / Q000737:chemistry; D006801:Humans; D009181:Mycoses / Q000188:drug therapy / Q000378:metabolism; D009503:Neutropenia / Q000209:etiology; D012995:Solubility
D000935:Antifungal Agents; D003840:Deoxycholic Acid; D000666:Amphotericin B